Ginkgo Bioworks Leverages Synthetic Biology and AI to Engineer Solutions to Global Issues
-
Ginkgo Bioworks uses synthetic biology and AI to engineer novel biological products that can solve major global issues.
-
Ginkgo's Foundry business creates custom organisms for clients, while its Codebase collects data to improve designs.
-
Partnership with Google Cloud allows Ginkgo to optimize its platform and gain new insights using AI.
-
Ginkgo's approach is appealing to pharma for accelerating drug development, with partners like Pfizer.
-
As a risky early-stage stock, Ginkgo has big vision to transform industries via synthetic bio, similar to Amazon in ecommerce.